IR

The realization of human health and happiness
We keep our principles for unchanging values.

Investors Financial Information.

Subject 2024 2023 2022
Current assets 129,651129,905114,188
Non-current assets 160,27596,90892,459
Total assets 289,926226,813206,647
Current liabilities 73,22174,08455,241
Non-current liabilities 60,1548,1017,247
Total liabilities 133,37582,18562,488
Capital 6,5216,5216,521
Capital surplus 11,37511,37511,375
Accumulated other comprehensive income 3,4493,4304,165
Other capital items (2,544) (2,544) (2,584)
Earned surplus 137,750125,846124,682
Total equity 156,551144,628144,159
Total liabilities and equity 289,926226,813206,647
Subject 2024 2023 2022
Sales 259,461 220,890 191,005
Gross profit 160,650 133,025 117,720
Selling and administrative expenses 140,338 114,969 98,275
Ordinary R&D expense 13,259 12,203 12,911
Operating profit 7,053 5,853 6,534
Earnings before taxes 18,612 7,744 3,599
Net income 15,178 4,353 2,123
Earning per share (won) 1,335 383 187
Diluted earnings per share (won) 1,335 383 187